Sanofi Statements
SA
Sanofi Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
9 743
4 695
5 048
—
1 297
2 701
2 347
-7
83
1 966
564
2 398
104.12
23.031
14 085
100
5 801
40.4
8 284
59.6
—
0
1 851
13.2
4 529
34.1
3 755
25.5
-7
-0.06
238
1.7
3 986
27.2
1 090
7.4
2 896
19.8
125.74
23.031
14 426
100
6 209
44.8
8 217
55.2
—
0
1 855
13.3
4 331
31.4
3 886
23.8
-10
-0.1
415
2.2
4 469
26
1 336
8.6
3 133
17.4
136.15
23.014
13 638
100
5 704
41.8
7 934
58.2
—
0
2 009
15.4
4 650
34.8
3 284
23.4
-9
-0.06
314
3
3 728
28.3
1 110
8.9
2 618
19.5
113.82
23
14 063
100
6 192
45.7
7 871
54.3
—
0
2 050
14.9
4 530
32.8
3 341
21.5
-8
-0.06
401
2.2
4 915
23.7
1 327
6.5
3 588
17.2
155.99
23
14 424
100
6 406
44.8
8 018
55.2
—
0
2 156
15.7
5 010
38.3
3 008
16.9
-9
-0.06
310
2.4
8 201
19.2
1 999
6.1
6 202
13.1
269.64
23
15 142
100
6 662
43.3
8 480
56.7
—
0
2 183
14.2
4 530
28
3 950
28.6
-9
-0.06
434
2.2
4 375
30.7
1 133
8.1
3 242
22.6
140.95
23
14 069
100
5 969
43.9
8 100
56.1
—
0
2 168
14.9
4 918
35.8
3 182
20.4
-8
-0.06
311
2.2
3 561
23.6
1 002
6.6
2 559
17.1
111.25
23
14 950
100
6 567
44.5
8 383
55.5
—
0
2 440
17.4
5 256
33.4
3 127
22.1
-10
-0.07
587
4.1
3 211
26.2
994
7.1
2 217
19.2
96.39
23
16 054
100
6 983
43.6
9 071
56.4
—
0
2 320
13.9
6 012
37.4
3 059
19
-3
-0.04
477
3
2 940
19.5
701
7.7
2 239
11.8
97.16
23.05
14 652
100
6 491
45.6
8 161
54.4
—
0
2 177
15.3
5 566
36.8
2 595
17.6
—
0
464
3.1
3 059
20.8
1 156
7.7
1 903
13
82.74
23